Effect of BMS-986165 on the Pharmacokinetics of Rosuvastatin

NCT03044873 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Diseases
Inflammatory Diseases

Interventions

DRUG: BMS-986165
DRUG: Rosuvastatin

Sponsor

Bristol-Myers Squibb